Select Committee report reported in the House of Commons on Thursday, 7 July 1994 from the Health Committee.
Priority setting in the NHS - the NHS drugs budget. Health Select Committee second report in 2 volumes with proceedings, evidence (previously HC 80 i-vii 1993/94 and HC 951 1992/93) and appendices. (Part 1 of 2)
Secondary information
- Type
- Parliamentary committee
- Reference
- HC 80 1993/94
- Session
- 1993-94
- Paper type
- House of Commons papers
- Subjects
- Cost effectiveness Costs Contraceptives Finance Drugs NHS Prescription drugs Age Concern Consumers Association Mersey Regional Health Authority Medicines Resource Centre South East Thames Regional Health Authority Cancer Research Campaign Fisons Cystic Fibrosis Trust Derbyshire Family Health Services Authority Medical Advisers Support Centre National Council for Hospice and Specialist Palliative Care Services Zeneca Evans, David Caremark American Pharmaceutical Group Arachnoiditis Self Help Group Barnet Family Health Services Authority British Geriatrics Society Bristol Myers Squibb Pharmaceuticals Cilag Dispensing Doctors Association Eastern Region Pharmaceutical Group European Society of Cardiology Guild of Hospital Pharmacists Lederle Laboratories London and Thames Valley Pharmaceutical Group Mersey Academic Pharmacy Practice Unit REMIT Consultants Rhône-Poulenc Society for Endocrinology Women in Medicine Thomas, David Howie, JGR Patch, Malcolm Furber, Tony Newton, Rogers
- Library location
- Commons Library: CS 598
Librarians' tools
- Timestamp
- 2025-01-24 21:06:51 +0000
- URI
- http://data.parliament.uk/pimsdata/Paper/28279
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Paper/28279
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Paper/28279